Cardiomyopathy in α-kinase 3 (Alpk3)-deficient mice

Veterinary Pathology

Volumn 49, Issue 1, 2012, Pages 131-141

  Van Sligtenhorst, I ^a   Ding, Z M ^a   Shi, Z Z ^a   Read, R W ^a   Hansen, G ^a   Vogel, Peter ^a  

^a LEXICON PHARMACEUTICALS INC   (United States)

Author keywords

kinase 3; cardiomyopathy; heart failure; intercalated discs; knockout mice

Indexed keywords

DOBUTAMINE; MIDORI PROTEIN, MOUSE; MUSCLE PROTEIN; PHOSPHOTRANSFERASE;

ANIMAL; ARTICLE; CARDIOMYOPATHY; DIASTOLE; DRUG EFFECT; FEMALE; GENE DELETION; GENETICS; HEART; HEART CONTRACTION; HEART FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; SYSTOLE;

ANIMALS; CARDIOMYOPATHIES; DIASTOLE; DOBUTAMINE; FEMALE; HEART; HEART FAILURE; HEART RATE; HEART VENTRICLES; HUMANS; MALE; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHOTRANSFERASES; SEQUENCE DELETION; STROKE VOLUME; SYSTOLE;

MUS;

EID: 84855384097     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985811402841     Document Type: Article

References (42)

1. Abuin A,Hansen GM,Zambrowicz B.Gene trap mutagenesis.Handb Exp Pharmacol. 2007; (178): 129-147.
2. Alcalai R,Seidman JG,Seidman CE.Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics.J Cardiovasc Electrophysiol. 2008;19:104-110.
3. Arber S,Hunter JJ,Ross J,Hongo M,Sansig G,Borg J, et al.MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure.Cell. 1997;88:393-403.
4. Bennett PM,Maggs AM,Baines AJ,Pinder JC.The transitional junction: a new functional subcellular domain at the intercalated disc.Mol Biol Cell. 2006;17:2091-2100.
5. Bentham J,Bhattacharya S.Genetic mechanisms controlling cardiovascular development.Ann N Y Acad Sci. 2008;1123:10-19.
6. Bruneau BG.The developmental genetics of congenital heart disease.Nature. 2008;451:943-948.
7. Chang AN,Potter JD.Sarcomeric protein mutations in dilated cardiomyopathy.Heart Fail Rev. 2005;10:225-235.
8. Chien KR.Genomic circuits and the integrative biology of cardiac diseases.Nature. 2000;407:227-232.
9. Clark K,Middelbeek J,Dorovkov MV,Figdor CG,Ryazanov AG,Lasonder E, et al.The alpha-kinases TRPM6 and TRPM7, but not eef-2 kinase, phosphorylate the assembly domain of myosin IIA, IIB and IIC.FEBS Lett. 2008;582:2993-2997.
10. Dalakas MC,Park KY,Semino-Mora C,Lee HS,Sivakumar K,Goldfarb LG.Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene.N Engl J Med. 2000;342:770-780.
11. Drennan D,Ryazanov AG.Alpha-kinases: analysis of the family and comparison with conventional protein kinases.Prog Biophys Mol Biol. 2004;85:1-32.
12. Ehler E,Horowits R,Zuppinger C,Price RL,Perriard E,Leu M, et al.Alterations at the intercalated disk associated with the absence of muscle LIM protein.J Cell Biol. 2001;153:763-772.
13. Ferreira-Cornwell MC,Luo Y,Narula N,Lenox JM,Lieberman M,Radice GL.Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart.J Cell Sci. 2002;115:1623-1634.
14. Freeman K,Colon-Rivera C,Olsson MC,Moore RL,Weinberger HD,Grupp IL, et al.Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene.Am J Physiol Heart Circ Physiol. 2001;280:H151-H159.
15. Hansen GM,Markesich DC,Burnett MB,Zhu Q,Dionne KM,Richter LJ, et al.Large-scale gene trapping in C57BL/6N mouse embryonic stem cells.Genome Res. 2008;18:1670-1679.
16. Hosoda T,Monzen K,Hiroi Y,Oka T,Takimoto E,Yazaki Y, et al.A novel myocyte-specific gene Midori promotes the differentiation of P19CL6 cells into cardiomyocytes.J Biol Chem. 2001;276:35978-35989.
17. Jordan MC,Zheng Y,Ryazantsev S,Rozengurt N,Roos KP,Neufeld EF.Cardiac manifestations in the mouse model of mucopolysaccharidosis I.Mol Genet Metab. 2005;86:233-243.
18. Kamisago M,Sharma SD,DePalma SR,Solomon S,Sharma P,McDonough B, et al.Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.N Engl J Med. 2000;343:1688-1696.
19. Kimura A.Molecular etiology and pathogenesis of hereditary cardiomyopathy.Circ J. 2008;72 (suppl A): A38-A48.
20. Lapidos KA,Kakkar R,McNally EM.The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma.Circ Res. 2004;94:1023-1031.
21. Li D,Tapscoft T,Gonzalez O,Burch PE,Quinones MA,Zoghbi WA, et al.Desmin mutation responsible for idiopathic dilated cardiomyopathy.Circulation. 1999;100:461-464.
22. Li Z,Colucci-Guyon E,Pincon-Raymond M,Mericskay M,Pournin S,Paulin D, et al.Cardiovascular lesions and skeletal myopathy in mice lacking desmin.Dev Biol. 1996;175:362-366.
23. Lin Q,Schwarz J,Bucana C,Olson EN.Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C.Science. 1997;276:1404-1407.
24. Mann DL.Mechanisms and models in heart failure: a combinatorial approach.Circulation. 1999;100:999-1008.
25. Maron BJ.Hypertrophic cardiomyopathy: a systematic review.J Am Med Assoc. 2002;287:1308-1320.
26. Maron BJ,Gardin JM,Flack JM,Gidding SS,Kurosaki TT,Bild DE.Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.Circulation. 1995;92:785-789.
27. Michels VV,Moll PP,Miller FA,Tajik AJ,Chu JS,Driscoll DJ, et al.The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy.N Engl J Med. 1992;326:77-82.
28. Morita H,Rehm HL,Menesses A,McDonough B,Roberts AE,Kucherlapati R, et al.Shared genetic causes of cardiac hypertrophy in children and adults.N Engl J Med. 2008;358:1899-1908.
29. Morita H,Seidman J,Seidman CE.Genetic causes of human heart failure.J Clin Invest. 2005;115:518-526.
30. Olson TM,Illenberger S,Kishimoto NY,Huttelmaier S,Keating MT,Jockusch BM.Metavinculin mutations alter actin interaction in dilated cardiomyopathy.Circulation. 2002;105:431-437.
31. Perriard JC,Hirschy A,Ehler E.Dilated cardiomyopathy: a disease of the intercalated disc?.Trends Cardiovasc Med. 2003;13:30-38.
32. Radice GL,Rayburn H,Matsunami H,Knudsen KA,Takeichi M,Hynes RO.Developmental defects in mouse embryos lacking N-cadherin.Dev Biol. 1997;181:64-78.
33. Richardson P,McKenna W,Bristow M,Maisch B,Mautner B,O'Connell J, et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation. 1996;93:841-842.
34. Soler AP,Knudsen KA.N-cadherin involvement in cardiac myocyte interaction and myofibrillogenesis.Dev Biol. 1994;162:9-17.
35. Thornell L,Carlsson L,Li Z,Mericskay M,Paulin D.Null mutation in the desmin gene gives rise to a cardiomyopathy.J Mol Cell Cardiol. 1997;29:2107-2124.
36. Towbin JA,Lowe AM,Colan SD,Sleeper LA,Orav EJ,Clunie S, et al.Incidence, causes, and outcomes of dilated cardiomyopathy in children.J Am Med Assoc. 2006;296:1867-1876.
37. Van Oort RJ,van Rooij E,Bourajjaj M,Schimmel J,Jansen MA,van der Nagel R, et al.MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure.Circulation. 2006;114:298-308.
38. Vasile VC,Will ML,Ommen SR,Edwards WD,Olson TM,Ackerman MJ.Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy.Mol Genet Metab. 2006;87:169-174.
39. Weitzer G,Milner DJ,Kim JU,Bradley A,Capetanaki Y.Cytoskeletal control of myogenesis: a desmin null mutation blocks the myogenic pathway during embryonic stem cell differentiation.Dev Biol. 1995;172:422-439.
40. Wilding JR,Joubert F,de Araujo C,Fortin D,Novotova M,Veksler V, et al.Altered energy transfer from mitochondria to sarcoplasmic reticulum after cytoarchitectural perturbations in mice hearts.J Physiol. 2006;575:191-200.
41. Zambrowicz BP,Abuin A,Ramirez-Solis R,Richter LJ,Piggott J,Beltrandelrio H, et al.Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention.Proc Natl Acad Sci U S A. 2003;100:14109-14114.
42. Zambrowicz BP,Friedrich GA,Buxton EC,Lilleberg SL,Person C,Sands AT.Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells.Nature. 1998;392:608-611.